Monkeypox Virus A33R Protein (Highly Pure)

<strong>Monkeypox Virus A33R Protein (Highly Pure)</strong>_x000D_ <strong>Catalog number:</strong> B2011532_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 44.1 kDa_x000D_ <strong>Supplied as:</strong> Lyophilized powder_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20℃_x000D_ <strong>Keywords:</strong> MPXV Protein A33R_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Reynolds MG, McCollum AM, Nguete B, Shongo Lushima R, Petersen BW. Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research Viruses. 2017 Dec 12;9(12):380._x000D_ 2: Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, Damon IK, Reynolds MG, Kuehnert MJ. Clinical characteristics of human monkeypox, and risk factors for severe disease Clin Infect Dis. 2005 Dec 15;41(12):1742-51._x000D_ 3: Tabarsi P. Human Monkeypox Iran J Med Sci. 2022 Jul;47(4):289-290._x000D_ 4: Isidro J, Borges V, Pinto M, Sobral D, Santos JD, Nunes A, Mixão V, Ferreira R, Santos D, Duarte S, Vieira L, Borrego MJ, Núncio S, de Carvalho IL, Pelerito A, Cordeiro R, Gomes JP. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus Nat Med. 2022 Aug;28(8):1569-1572._x000D_ 5: Absil G, Sougne L, Lahrichi D, Collins P, Meuris C, Moutschen M, Nikkels AF, Orban C. [Monkeypox] Emerg Infect Dis. 2018 Jun;24(6):1149-1151. doi: 10.3201/eid2406.180017. Epub 2018 Jun 17._x000D_ 6: Yinka-Ogunleye A, Aruna O, Ogoina D, Aworabhi N, Eteng W, Badaru S, Mohammed A, Agenyi J, Etebu EN, Numbere TW, Ndoreraho A, Nkunzimana E, Disu Y, Dalhat M, Nguku P, Mohammed A, Saleh M, McCollum A, Wilkins K, Faye O, Sall A, Happi C, Mba N, Ojo O, Ihekweazu C. Reemergence of Human Monkeypox in Nigeria, 2017 Emerg Infect Dis. 2018 Jun;24(6):1149-1151._x000D_ 7: Harapan H, Setiawan AM, Yufika A, Anwar S, Wahyuni S, Asrizal FW, Sufri MR, Putra RP, Wijayanti NP, Salwiyadi S, Maulana R, Khusna A, Nusrina I, Shidiq M, Fitriani D, Muharrir M, Husna CA, Yusri F, Maulana R, Andalas M, Wagner AL, Mudatsir M. Knowledge of human monkeypox viral infection among general practitioners: a cross-sectional study in Indonesia Pathog Glob Health. 2020 Mar;114(2):68-75._x000D_ 8: Hammerschlag Y, MacLeod G, Papadakis G, Adan Sanchez A, Druce J, Taiaroa G, Savic I, Mumford J, Roberts J, Caly L, Friedman D, Williamson DA, Cheng AC, McMahon JH. Monkeypox infection presenting as genital rash, Australia, May 2022 Euro Surveill. 2022 Jun;27(22):2200411._x000D_ 9: Rimoin AW, Graham BS. Whither monkeypox vaccination Vaccine. 2011 Dec 30;29 Suppl 4(Suppl 4):D60-4._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/14736926">10: Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, Kazmierczak JJ, Stratman EJ, Li Y, Fairley JA, Swain GR, Olson VA, Sargent EK, Kehl SC, Frace MA, Kline R, Foldy SL, Davis JP, Damon IK. The detection of monkeypox in humans in the Western Hemisphere N Engl J Med. 2004 Jan 22;350(4):342-50. </a>_x000D_ _x000D_ <strong>Products Related to Monkeypox Virus A33R Protein (Highly Pure) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>